Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration.

Victor A EngNadim Rayess Huy V Nguyen Theodore Leng

Published in: PloS one (2020)

Treating nAMD with aflibercept, bevacizumab or ranibizumab demonstrated comparable cRORA development at 24 months. Number of injections inversely correlated with cRORA area and growth. These results warrant further investigation in the pathophysiology of cRORA in anti-VEGF treated eyes.

Keyphrases

age related macular degeneration
optical coherence tomography
vascular endothelial growth factor
endothelial cells
diabetic retinopathy
ultrasound guided
platelet rich plasma
combination therapy
metastatic colorectal cancer